Details for Patent: 10,603,384
✉ Email this page to a colleague
Which drugs does patent 10,603,384 protect, and when does it expire?
Patent 10,603,384 protects PREVYMIS and is included in one NDA.
This patent has forty-two patent family members in thirty-five countries.
Summary for Patent: 10,603,384
| Title: | Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative |
| Abstract: | The invention relates to pharmaceutical compositions, particularly for intravenous administration, containing {8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-[2-methoxy-5-(trifluor- omethyl)phenyl]-3,4-dihydroquinazoline-4-yl}acetic acid in combination with at least one of the cyclodextrin excipients, lysine and arginine; the method for its production; and its use in methods of treatment of and/or as a prophylactic for illnesses, particularly its use as an antiviral, preferably against cytomegaloviruses. |
| Inventor(s): | Paulus; Kerstin (Ratingen, DE), Schwab; Wilfried (Velbert, DE), Grunder; Dominique (Belp, CH), Van Hoogevest; Peter (Neustadt an der Weinstrasse, DE) |
| Assignee: | AICURIS GMBH & CO. KG (Wuppertal, DE) |
| Application Number: | 14/381,290 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Delivery; |
Drugs Protected by US Patent 10,603,384
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | PREVYMIS | letermovir | SOLUTION;INTRAVENOUS | 209940-001 | Nov 8, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Merck Sharp Dohme | PREVYMIS | letermovir | SOLUTION;INTRAVENOUS | 209940-002 | Nov 8, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,603,384
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 10 2012 101 680 | Feb 29, 2012 |
| PCT Information | |||
| PCT Filed | February 28, 2013 | PCT Application Number: | PCT/EP2013/054114 |
| PCT Publication Date: | September 06, 2013 | PCT Publication Number: | WO2013/127970 |
International Family Members for US Patent 10,603,384
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013224947 | ⤷ Try a Trial | |||
| Brazil | 112014020946 | ⤷ Try a Trial | |||
| Canada | 2865203 | ⤷ Try a Trial | |||
| Chile | 2014002306 | ⤷ Try a Trial | |||
| China | 104144678 | ⤷ Try a Trial | |||
| China | 110433166 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
